Experts found a revolutionary drug that could block tumor growth. In fact, this new drug, according to Newscientist, is able to prevent metastatic spread or tumor growth.
A new drug called cabozantinib or cabo is manufactured by a pharmaceutical company called Exelixis. To test this, Donald McDonald from the University of California in San Francisco and his colleagues conducted experiments with rats, that were diagnosed with a malignant tumor.
A group of rats received daily doses of cabozantinib for 14 weeks. After 20 weeks, all rats survived. But none of the rodents can survive that long when injected with placebo.
Cancer expert Holger Gerhardt, said there were no metastases or tumor growth retention for more than 20 weeks. It has never been observed in similar studies. The innovative nature of this new drug not only inhibits vascular endothelial growth receptors, which stops tumor growth, but also inhibits metastasis, and blocking blood flow to the tumor.
Trials were also conducted on 108 human volunteers who had prostate cancer and bone metastases, with cabozantinib for three months. The result, the size of the tumor in the bone of 82 people declined or disappeared altogether.
Growing tumors only occurred in three patients during treatment. Two-thirds of patients reported positive effects of drugs that act as painkillers. Patients admitted the drug intake did not make them give up and ask for an injection of morphine.
The new drug test is now continued in 246 patients to reduce pain, and another study on 960 patients to test whether this revolutionary drug can extend life expectancy.
Cabozantinib is considered the first drug that affects 12 of the 13 types of cancer. Though generally, testing a new cancer drug therapy does no function in 9 out of 10 types of tumor.Tagged with: cabo, cabozantinib, cancer distroyer, new cancer drug, new drug for cancer, new hope for cancer,